How many companies in the world can produce over 10 tonnes per annum of Battery grade Lithium Carbonate with a market cap of less than 400m?
Once you have answered that question, consider the unique opportunity that Argosy presents. To focus on this investment, you will be required to shut out a lot of noise. It's a discipline thing.
I remember when PLS and ORE (now AKE) were getting hammered by the shorters. To even raise a positive viewpoint was to invite a lot of scorn. Day after day, week after week, month after month of depressingly lower prices. Then the fall stuttered to a halt, the doomsdayers crazy predictions failed to eventuate and since then those that failed to invest in what seemed like an enormous risk as the time, have regretted it.
I remember buying AGY at 7 cents, 6 cents, 5 cents, then it fell below 5 cents and I wondered if I had done my dough. The mockers discussed the donkey incident, the gas debacle, funding, resource size etc etc, which made buying back then feel pretty stupid, I can assure you. However, I did'nt wonder if I had done my dough, when the SP rose from 50 to 60 cents, 60 to 70 cents, nor from 70 to 80 cents, but I did listen to some wise old heads who suggested it is best to take some profit off the table. Will it get to 80 cents again? I think so, but I don't know for sure. No-one does. So, a lot of possible reasons for why the top is in, are being thrown at us.
Back to the opening paragraph, this is a unique opportunity. The current price makes this a compelling, unique opportunity. I am buying again. All the best to my fellow investors. Asterix and Obelix used to say, these Romans are crazy. If they were invested in AGY, they would probably say, these prices are crazy!
- Forums
- ASX - By Stock
- AGY
- Li-related News/Articles/Reports
Li-related News/Articles/Reports, page-4837
-
- There are more pages in this discussion • 4,096 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
|
|||||
Last
8.5¢ |
Change
-0.008(8.60%) |
Mkt cap ! $123.7M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 8.5¢ | $362.9K | 4.093M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 93664 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 0.085 |
3 | 99873 | 0.084 |
4 | 169062 | 0.083 |
3 | 336585 | 0.082 |
2 | 114691 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 93664 | 1 |
0.088 | 232558 | 1 |
0.089 | 69615 | 2 |
0.090 | 91167 | 2 |
0.091 | 52101 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online